About this trial
1\. To research the current situation of severe infection in children in China, and to investigate the incidence, prognosis and disease burden of severe infection in children in different regions of China. 2. Establish the risk prediction model and diagnosi model of severe infection in children, and verify the accuracy of the model in multi-center; 3. To study the effectiveness and safety of different treatments in real diagnosis and treatment, and to evaluate the efficacy of subgroups under different ages and high risk factors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children between 0 and 18 years old.
Severe pneumonia and/or sepsis.
Disqualifiers
notifiable infectious diseases.
The researcher believes that he is not suitable to participate in other situations in this study.
Participants in other clinical trials in the same period.
Trial population
All children hospitalized in PICU of Children's Hospital of Fudan University from April 2021 to April 2025
Trial design
Other
Prospective
Treatments tested in this trial
Not applicable(Cohort study)
Other interventionThis is a prospective observational study and does not include interventions.
Treatment groups
Trial outcomes
Primary outcomes
survival rate
The survival rate of children in 28 days after their discharged from PICU
Secondary outcomes
length of stay in PICU
Time from PICU admission to discharge
Sponsors and contacts
Click on the lead sponsor to view all of their trials.